NCT04743661 2026-02-05131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor ConsortiumPhase 2 Active not recruiting62 enrolled
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled